financetom
Business
financetom
/
Business
/
Plum Acquisition Corp. IV Prices IPO at $10 per Unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Plum Acquisition Corp. IV Prices IPO at $10 per Unit
Jan 15, 2025 1:21 AM

03:56 AM EST, 01/15/2025 (MT Newswires) -- Plum Acquisition Corp. IV ( PLMKU ) said late Tuesday it has priced an initial public offering of 15 million units at $10 per unit.

The units are expected to be listed for trading on Nasdaq under the ticker symbol "PLMKU" beginning Wednesday, the blank-check company said.

Each unit consists of one ordinary share and one-half of a redeemable warrant, with each whole warrant entitling the holder to purchase an ordinary share for $11.50, the company said.

Once the securities begin separate trading, the ordinary shares and warrants are due to be listed under the symbols "PLMK" and "PLMKW," respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BlackRock Loses Tax Deduction-Related Appeal in UK
BlackRock Loses Tax Deduction-Related Appeal in UK
Apr 11, 2024
12:39 PM EDT, 04/11/2024 (MT Newswires) -- BlackRock ( BLK ) lost an appeal related to the deductibility for UK tax purposes of interest payable on $4 billion of intra-group loans put in place in connection with its acquisition of Barclays Global Investors in 2009, according to a UK Court of Appeal decision Thursday. The court ruled in favor of...
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Apr 11, 2024
April 11 (Reuters) - A U.S. appeals court on Thursday affirmed a decision for Bausch Health ( BHC ) that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029. A Delaware federal court had determined that Alvogen subsidiary Norwich Pharmaceuticals' generic would infringe patents owned by Bausch's Salix Pharmaceuticals. It blocked the...
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Apr 11, 2024
Eliem Therapeutics Inc ( ELYM ) has agreed to acquire Tenet Medicines Inc., a development-stage private biotechnology company.  The combined company plans to focus on advancing TNT119, an anti-CD19 antibody designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. In June 2023, Eliem Therapeutics ( ELYM ) completed a review of its business, including the...
Market Chatter: Amazon Looking to Invest in UK Tech Startups With Innovation Fund
Market Chatter: Amazon Looking to Invest in UK Tech Startups With Innovation Fund
Apr 11, 2024
12:41 PM EDT, 04/11/2024 (MT Newswires) -- Amazon.com ( AMZN ) is in active conversations for possible funding support for UK-based technology startups via the e-commerce company's $1 billion industrial innovation fund, City A.M. reported Thursday. Franziska Bossart, a director of the fund, told the newspaper that the fund has invested in 12 startups in the US and Israel. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved